HVD(P)s? [Regulatives / Guidelines]

posted by 0521 – China, 2021-01-04 13:10 (1399 d 17:29 ago) – Posting: # 22168
Views: 2,311

❝ In the future & if in doubt see the [image] Abbreviations on top of the page.


It looks great, maybe you can open up editing permissions to allow others to create comparison tables of words and descriptions in other languages.

"RSABE of highly variable drugs" is that.

Beijing time: October 29, 2018, public.

Chinese: 高变异药物生物等效性研究技术指导原则
English: Guidance for Industry: the study of drug bioequivalence with highly variable drugs

webpage:
http://www.cde.org.cn/zdyz.do?method=largePage&id=3fa6c1797e66be98

PDF:
http://www.cde.org.cn/attachmentout.do?mothed=list&id=caf29fdd9abce51e


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,280 posts in 4,889 threads, 1,655 registered users;
53 visitors (0 registered, 53 guests [including 9 identified bots]).
Forum time: 06:39 CET (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5